These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 18949948)

  • 1. Controversies in chronic kidney disease, anaemia and cardiovascular disease.
    Fluck R
    Br J Hosp Med (Lond); 2008 Oct; 69(10):580-6. PubMed ID: 18949948
    [No Abstract]   [Full Text] [Related]  

  • 2. The KDIGO anemia guideline: can reason triumph over regulation?
    Wish JB
    Nephrol News Issues; 2012 Dec; 26(13):20, 22-3. PubMed ID: 23346853
    [No Abstract]   [Full Text] [Related]  

  • 3. Applying evidence into routine clinical care at a unit level: the exemplar of renal anaemia management.
    Gallagher MP; Cass A; Craig JC
    Nephrology (Carlton); 2010 Jun; 15(4):429-33. PubMed ID: 20609094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Would prescription of erythropoiesis-stimulating agents in pre-dialysis change after results from TREAT study?].
    Alcázar R; Tato A; García F; Barrios V; Quereda C
    Nefrologia; 2010; 30(1):114-8. PubMed ID: 20038963
    [No Abstract]   [Full Text] [Related]  

  • 5. Transition of patients from chronic kidney disease to end-stage renal disease: better practices for better outcomes.
    Amedia CA; Perazella MA
    Dis Manag; 2006 Dec; 9(6):311-5. PubMed ID: 17115878
    [No Abstract]   [Full Text] [Related]  

  • 6. Potential mechanisms of adverse outcomes in trials of anemia correction with erythropoietin in chronic kidney disease.
    Vaziri ND; Zhou XJ
    Nephrol Dial Transplant; 2009 Apr; 24(4):1082-8. PubMed ID: 18987263
    [No Abstract]   [Full Text] [Related]  

  • 7. ESAs in dialysis patients: are you a hedgehog or a fox?
    Singh AK
    J Am Soc Nephrol; 2010 Apr; 21(4):543-6. PubMed ID: 20357173
    [No Abstract]   [Full Text] [Related]  

  • 8. The FDA's perspective on the risk for rapid rise in hemoglobin in treating CKD anemia: Quo Vadis.
    Singh AK
    Clin J Am Soc Nephrol; 2010 Apr; 5(4):553-6. PubMed ID: 20203166
    [No Abstract]   [Full Text] [Related]  

  • 9. [Progress in blood purification medicine in 2011].
    Takeda T
    Nihon Jinzo Gakkai Shi; 2012; 54(1):11-6. PubMed ID: 22413573
    [No Abstract]   [Full Text] [Related]  

  • 10. Nurse-coordinated care in CKD: time for translation into practice?
    Smith DH; Thorp ML
    Clin J Am Soc Nephrol; 2011 Jun; 6(6):1229-31. PubMed ID: 21617089
    [No Abstract]   [Full Text] [Related]  

  • 11. [Regarding the optimal hemoglobin target range in renal anemia].
    Maurin N
    Med Klin (Munich); 2008 Sep; 103(9):633-7. PubMed ID: 18813886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An assessment of cholesterol goal attainment in patients with chronic kidney disease.
    Stadler SL; Bhardwaja B; Olson KL; Powers JD; Lanese D
    J Clin Lipidol; 2010; 4(4):298-304. PubMed ID: 21122663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survey of attitude of physicians on updates in the management of anemia in chronic kidney disease patients.
    Souqiyyeh MZ; Shaheen FA
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):410-6. PubMed ID: 19414943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dialysis after kidney transplant failure: do patients start in a worse condition than the general population with chronic kidney disease?
    Caldés Ruisánchez S; Marcén Letosa R; Amezquita Orjuela Y; Fernández Lucas M; Rivera Gorrin M; Galeano Álvarez C; Fernández Rodríguez A; Teruel Briones JL; Quereda Rodríguez-Navarro C
    Nefrologia; 2011; 31(1):51-7. PubMed ID: 21270913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triumph and tragedy: anemia management in chronic kidney disease.
    Novak JE; Szczech LA
    Curr Opin Nephrol Hypertens; 2008 Nov; 17(6):580-8. PubMed ID: 18941350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are there implications from the Trial to Reduce Cardiovascular Events with Aranesp Therapy study for anemia management in dialysis patients?
    Berns JS
    Curr Opin Nephrol Hypertens; 2010 Nov; 19(6):567-72. PubMed ID: 20601876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Transfusion requirements in chronic kidney disease].
    Frimat L
    Transfus Clin Biol; 2008 Nov; 15(5):214-6. PubMed ID: 18938100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardio-renal-anemia syndrome: a report of three cases.
    Okafor UH; Unuigbe EI
    Saudi J Kidney Dis Transpl; 2012 May; 23(3):562-8. PubMed ID: 22569446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cardiovascular disease in patients with 4 and 5 stage chronic kidney disease. Patient in chronic dialysis].
    Goicoechea MA
    Nefrologia; 2004; 24 Suppl(6):142-60, 187-235. PubMed ID: 15696904
    [No Abstract]   [Full Text] [Related]  

  • 20. [Guidelines of the Spanish Society of Nephrology: the kidney and cardiovascular disease. Short version].
    Marín R; Goicoechea MA; Gorostidi M; Cases A; Díez J; Escolar G; Fernández-Vega F; Palomar R; Rodrigo E; Martínez I; Segura J;
    Nefrologia; 2006; 26(1):31-44. PubMed ID: 16649424
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.